BioSphere Medical, Inc. Schedules Third Quarter 2009 Financial Results Conference Call October 29

ROCKLAND, Mass.--(BUSINESS WIRE)--BioSphere Medical, Inc. (NASDAQ:BSMD), the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors, and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy, today announced that it plans to issue its financial results for the third quarter ended September 30, 2009 on October 28 after the close of the stock market. Management will conduct a conference call on Thursday, October 29 at 8:30 a.m. Eastern Time to discuss these results.